Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
No of Months
12
12
12
12
12
Operating Income
632.00
398.00
214.00
35.00
14.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
Net Sales
632.00
398.00
214.00
35.00
14.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
3.00
0.00
-2.00
Raw Materials Consumed
251.00
181.00
102.00
13.00
10.00
Power & Fuel Cost
10.00
9.00
2.00
0.00
0.00
Employee Cost
112.00
60.00
35.00
4.00
2.00
Operating Expenses
34.00
31.00
11.00
0.00
0.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
6.00
3.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
4.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
Total Expenditure
464.00
308.00
172.00
22.00
12.00
Operating Profit (PBDIT) excl Other Income
168.00
89.00
41.00
12.00
1.00
Other Income
47.00
19.00
2.00
3.00
0.00
Operating Profit (PBDIT)
215.00
108.00
44.00
16.00
2.00
Interest
25.00
21.00
9.00
2.00
0.00
Profit before Depriciation and Tax
190.00
87.00
34.00
14.00
1.00
Depreciation
31.00
16.00
10.00
1.00
0.00
Profit Before Taxation & Exceptional Items
159.00
70.00
24.00
12.00
1.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
159.00
70.00
24.00
12.00
1.00
Provision for Tax
37.00
12.00
-7.00
4.00
0.00
Profit After Tax
121.00
58.00
32.00
8.00
0.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
89.00
41.00
10.00
1.00
0.00
Profit Available for appropriations
205.00
100.00
41.00
10.00
1.00
Appropriations
205.00
100.00
41.00
10.00
1.00
Equity Dividend (%)
0.00%
0.00%
0.00%
0.00%
0.00%
Earnings Per Share
26.39
16.12
13.67
8.87
1.81
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 58.85% vs 85.65% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 87.65% vs 115.68% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 16.15% vs 128.04% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 108.31% vs 78.36% in Mar 2025
Compare Profit and Loss Results of Senores Pharma.
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
632.00
1,811.00
-1,179.00
-65.10%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
632.00
1,811.00
-1,179.00
-65.10%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-47.00
47.00
100.00%
Raw Materials Consumed
251.00
1,206.00
-955.00
-79.19%
Power & Fuel Cost
10.00
40.00
-30.00
-75.00%
Employee Cost
112.00
208.00
-96.00
-46.15%
Operating Expenses
34.00
50.00
-16.00
-32.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
6.00
79.00
-73.00
-92.41%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
4.00
25.00
-21.00
-84.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
464.00
1,637.00
-1,173.00
-71.66%
Operating Profit (PBDIT) excl Other Income
168.00
174.00
-6.00
-3.45%
Other Income
47.00
18.00
29.00
161.11%
Operating Profit (PBDIT)
215.00
192.00
23.00
11.98%
Interest
25.00
8.00
17.00
212.50%
Profit before Depriciation and Tax
190.00
184.00
6.00
3.26%
Depreciation
31.00
28.00
3.00
10.71%
Profit Before Taxation & Exceptional Items
159.00
155.00
4.00
2.58%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
159.00
155.00
4.00
2.58%
Provision for Tax
37.00
37.00
0.00
0.00%
Profit After Tax
121.00
118.00
3.00
2.54%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
89.00
286.00
-197.00
-68.88%
Profit Available for appropriations
205.00
404.00
-199.00
-49.26%
Appropriations
205.00
404.00
-199.00
-49.26%
Equity Dividend (%)
0%
10%
-10.00
Earnings Per Share
26.39
2.2
24.19
1,099.55%
Profit And Loss - Net Sales
Net Sales 632.63 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 58.85% vs 85.65% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 168.32 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 87.65% vs 115.68% in Mar 2025
Profit And Loss - Interest
Interest 25.03 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 16.15% vs 128.04% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 121.53 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 108.31% vs 78.36% in Mar 2025